Perspective Therapeutics (CATX) Current Assets (2011 - 2026)

Perspective Therapeutics has disclosed Current Assets across 16 years of filings, most recently posting $241.5 million for Q2 2026.

• In Q2 2026, Current Assets rose 23.25% year-over-year to $241.5 million; the TTM figure through Jun 2026 stood at $241.5 million (up 23.25% YoY), while the FY2025 annual figure was $148.4 million, down 35.81% from the prior year.
• Current Assets came in at $241.5 million for Q2 2026 at Perspective Therapeutics, down from $275.4 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $294.2 million in Q2 2024 to a low of $16.8 million in Q4 2023.
• Average Current Assets over 5 years is $143.5 million, with a median of $163.4 million recorded in 2025.
• Year-over-year, Current Assets tumbled 68.36% in 2023 and jumped 1272.93% in 2024.
• Over 5 years, Current Assets stood at $53.2 million in 2022, then plunged by 68.36% to $16.8 million in 2023, then jumped by 1272.93% to $231.2 million in 2024, then plunged by 35.81% to $148.4 million in 2025, then jumped by 62.76% to $241.5 million in 2026.
• Per Business Quant data, the three most recent Current Assets figures were $241.5 million in Q2 2026, $275.4 million in Q1 2026, and $148.4 million in Q4 2025.